Seiji Miyahara - Profile and Investment Details

Investor Profile

Seiji Miyahara is a Venture Capital, Investor based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Anavo Therapeutics BV, Breakpoint Therapeutics GmbH, EpiBiologics, Transition Bio, Inc., Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure, Storm Therapeutics, Axial Biotherapeutics, ORIC Pharmaceuticals, Light Horse Therapeutics, Dren Bio, Magnet BiomedicineTaiho Ventures, LLC, Arcus Biosciences, Orna Therapeutics, Breakpoint Therapeutics, . Over time, Seiji Miyahara has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Seiji Miyahara is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Manufacturing, Biotechnology, Health and Hospital Services, Research, Medical, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Seiji Miyahara, as their portfolio suggests a familiarity and interest in this area.

Understanding Seiji Miyahara’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.